Wird geladen...
Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers
Esophagogastric cancers (EGCa) are a leading cause of cancer related mortality worldwide. It has been recognized that they represent heterogenous diseases based on histology and anatomy. However, it is also increasingly evident that these are diverse malignancies based on genetic alterations, and th...
Gespeichert in:
| Veröffentlicht in: | J Gastrointest Oncol |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AME Publishing Company
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056259/ https://ncbi.nlm.nih.gov/pubmed/27747090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.08.13 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|